Cell Therapy Industry 2027: It’s not all about therapies

by David Brindley | Oct 25, 2013

. Nestled in the bosom of the Canadian Rockies, the global regenerative medicine community is assembled. Coaches laden with young investigators sporting impractically packed posters and drawn, jet lagged expressions are arriving in a steady procession. The usually...

Mountains in Banff: From theoretical stem cells to the real deal

by Guest | Oct 25, 2013

Guest post by Paul Knoepfler, cross-posted on ipscell.com This morning I particularly enjoyed a talk by Sui Huang [ed note: this talk also discussed here] focused on the application of mathematics as a tool to understand cell behavior and fate. I love this stuff! I...

StemCellShorts 3: What are induced pluripotent stem cells?

by Ben Paylor | Oct 25, 2013

“Canada is home to numerous stem cell discoveries and StemCellShorts is an excellent medium through which we can convey these accomplishments to Canadians and others worldwide.  The ‘shorts’ are innovative, educational and entertaining”.  — Dr. Mick Bhatia,...

Cell Therapy Industry 2027: Managing expectation through effective communication

by David Brindley | Oct 24, 2013

. 9am, Day 1: IBC Cell Therapy Bioprocessing Conference (Bethesda, MD, USA): Attempting to sharpen tie, and my welcome isolation is interrupted by a lady entering the elevator and fighting for mirror space. Cue small talk: “That’s a nice tie.” “Erm, thank you.” “And...

Day 2 at #TMM2013: Outliers and Rebellious Cells

by David Kent | Oct 24, 2013

> Day 2 of TMM2013 began with a video link shared session between this meeting here in Banff and another happening in Leipzig. It was a pretty cool idea and underscores two neat things about the Canadian Stem Cell Network and CCRM. First, despite being viewed as a...

Jailbreaking cell fate reprograms to multiple stem cell types says Nagy

by Guest | Oct 24, 2013

Guest post by Paul Knoepfler, cross-posted on ipscell.com You can jailbreak your iPhone, but perhaps you can jailbreak a cell too to turn it into a stem cell. In his very cool talk up here at the Till & McCulloch Meeting on Stem Cells yesterday, Andras Nagy...

Day 1 at #TMM2013: Hongkui Deng breaks down iPS cells

by David Kent | Oct 23, 2013

> Set in the beautiful mountain setting of Banff National Park, the first hours of the Till and McCulloch meeting have not disappointed. Our morning plenary began with an excellent historical perspective from Shin-Ichi Nishikawa on the origins of blood stem cells...

Cell Therapy Industry 2027: A Vernian Voyage

by David Brindley | Oct 23, 2013

. The Cell Therapy Industry’s equivalent of ‘Wimbledon Fortnight,’ is upon us: ARM’s successfully delivered Meeting on the Mesa (La Jolla, CA) has served as a tantalizing hors d’oeuvre to IBC’s Cell Therapy Bioprocessing Conference (Bethesda, MD) and CCRM’s and...

Jacob Hanna on Radically Deterministic Reprogramming @TMM2013

by Guest | Oct 23, 2013

Guest post by Paul Knoepfler, cross-posted on ipscell.com What is “radically deterministic” cellular reprogramming? Jacob Hanna’s lab recently published a very high profile Nature paper on nearly 100% efficient iPS cell formation based on targeting a...

Alberta bound: 6 reasons to follow the Till & McCulloch Meetings

by Lisa Willemse | Oct 21, 2013

> If the thought of majestic mountains, impossibly blue skies and natural hot springs isn’t enough to put Banff, Alberta into your calendar this week, then perhaps this preview of the Till & McCulloch Meetings will change your mind. This is the second...